Gilead Sciences IncNASDAQ:GILD
- LAST PRICE83.8400
- TODAY'S CHANGE (%)0.2300 (0.2751%)
- Bid / Lots83.0500/ 1
- Ask / Lots83.8100/ 14
- Open / Previous Close83.1500 / 83.6100
- Day Range
- 52 Week Range
- Volume5,096,843
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | GILD |
|---|---|---|
| 09:32 ET | 107418 | 83.47 |
| 09:34 ET | 20006 | 83.395 |
| 09:36 ET | 21614 | 83.352003 |
| 09:38 ET | 10508 | 83.465 |
| 09:39 ET | 10035 | 83.42 |
| 09:41 ET | 7472 | 83.425 |
| 09:43 ET | 26855 | 83.635 |
| 09:45 ET | 12770 | 83.65 |
| 09:48 ET | 8027 | 83.615 |
| 09:50 ET | 12461 | 83.53 |
| 09:52 ET | 12954 | 83.49 |
| 09:54 ET | 6180 | 83.51 |
| 09:56 ET | 14791 | 83.67 |
| 09:57 ET | 11299 | 83.6 |
| 09:59 ET | 7688 | 83.66 |
| 10:01 ET | 54384 | 83.755 |
| 10:03 ET | 16369 | 83.875 |
| 10:06 ET | 9307 | 83.99 |
| 10:08 ET | 18338 | 84.09 |
| 10:10 ET | 14498 | 84.23 |
| 10:12 ET | 22095 | 84.2 |
| 10:14 ET | 32802 | 84.035 |
| 10:15 ET | 10210 | 84.01 |
| 10:17 ET | 10833 | 83.99 |
| 10:19 ET | 10061 | 84.045 |
| 10:21 ET | 5196 | 83.97 |
| 10:24 ET | 27650 | 83.86 |
| 10:26 ET | 14205 | 83.86 |
| 10:28 ET | 20374 | 84.0886 |
| 10:30 ET | 7642 | 84.05 |
| 10:32 ET | 11840 | 84.07 |
| 10:33 ET | 15609 | 84.09 |
| 10:35 ET | 7060 | 83.985 |
| 10:37 ET | 5185 | 84.03 |
| 10:39 ET | 7043 | 84.1 |
| 10:42 ET | 12380 | 84.08 |
| 10:44 ET | 8610 | 84.05 |
| 10:46 ET | 12395 | 83.95 |
| 10:48 ET | 5573 | 84.01 |
| 10:50 ET | 8376 | 84.06 |
| 10:51 ET | 5103 | 83.985 |
| 10:53 ET | 6348 | 83.99 |
| 10:55 ET | 3682 | 84.04 |
| 10:57 ET | 8300 | 84.08 |
| 11:00 ET | 8296 | 84.07 |
| 11:02 ET | 5973 | 84.04 |
| 11:04 ET | 7661 | 84.006 |
| 11:06 ET | 7280 | 83.96 |
| 11:08 ET | 8489 | 83.975 |
| 11:09 ET | 6999 | 83.97 |
| 11:11 ET | 5821 | 83.99 |
| 11:13 ET | 5380 | 83.95 |
| 11:15 ET | 7545 | 83.995 |
| 11:18 ET | 7065 | 84.045 |
| 11:20 ET | 6413 | 84.05 |
| 11:22 ET | 8361 | 84.055 |
| 11:24 ET | 8825 | 84.01 |
| 11:26 ET | 10653 | 84.02 |
| 11:27 ET | 8036 | 83.92 |
| 11:29 ET | 13901 | 83.81 |
| 11:31 ET | 6402 | 83.78 |
| 11:33 ET | 8300 | 83.76 |
| 11:36 ET | 8916 | 83.74 |
| 11:38 ET | 18402 | 83.72 |
| 11:40 ET | 4519 | 83.7 |
| 11:42 ET | 3635 | 83.7 |
| 11:44 ET | 7439 | 83.63 |
| 11:45 ET | 2300 | 83.6 |
| 11:47 ET | 859 | 83.61 |
| 11:49 ET | 3319 | 83.62 |
| 11:51 ET | 4380 | 83.55 |
| 11:54 ET | 2314 | 83.5401 |
| 11:56 ET | 2422 | 83.56 |
| 11:58 ET | 3433 | 83.52 |
| 12:00 ET | 3018 | 83.51 |
| 12:02 ET | 3879 | 83.525 |
| 12:03 ET | 5124 | 83.52 |
| 12:05 ET | 1934 | 83.49 |
| 12:07 ET | 4142 | 83.510078 |
| 12:09 ET | 10403 | 83.48 |
| 12:12 ET | 2592 | 83.47 |
| 12:14 ET | 2933 | 83.44 |
| 12:16 ET | 2034 | 83.45 |
| 12:18 ET | 3333 | 83.425 |
| 12:20 ET | 5276 | 83.43 |
| 12:21 ET | 3264 | 83.43 |
| 12:23 ET | 5452 | 83.44 |
| 12:25 ET | 2924 | 83.44 |
| 12:27 ET | 1566 | 83.44 |
| 12:30 ET | 3157 | 83.49 |
| 12:32 ET | 4213 | 83.4852 |
| 12:34 ET | 3790 | 83.47 |
| 12:36 ET | 1982 | 83.47 |
| 12:38 ET | 2691 | 83.5 |
| 12:39 ET | 3900 | 83.46 |
| 12:41 ET | 8071 | 83.385 |
| 12:43 ET | 5249 | 83.37 |
| 12:45 ET | 6555 | 83.38 |
| 12:48 ET | 7002 | 83.37 |
| 12:50 ET | 1500 | 83.34 |
| 12:52 ET | 6514 | 83.31 |
| 12:54 ET | 4339 | 83.305 |
| 12:56 ET | 5422 | 83.3 |
| 12:57 ET | 3871 | 83.3376 |
| 12:59 ET | 20469 | 83.45 |
| 01:01 ET | 7437 | 83.49 |
| 01:03 ET | 3174 | 83.48 |
| 01:06 ET | 2836 | 83.47 |
| 01:08 ET | 3429 | 83.49 |
| 01:10 ET | 10734 | 83.5 |
| 01:12 ET | 1140 | 83.465 |
| 01:14 ET | 13061 | 83.4804 |
| 01:15 ET | 2235 | 83.46 |
| 01:17 ET | 3699 | 83.47 |
| 01:19 ET | 3709 | 83.47 |
| 01:21 ET | 3887 | 83.4701 |
| 01:24 ET | 4674 | 83.47 |
| 01:26 ET | 3249 | 83.48 |
| 01:28 ET | 34782 | 83.52 |
| 01:30 ET | 7465 | 83.48 |
| 01:32 ET | 3496 | 83.43 |
| 01:33 ET | 3692 | 83.4631 |
| 01:35 ET | 3203 | 83.48 |
| 01:37 ET | 8271 | 83.45 |
| 01:39 ET | 5826 | 83.45 |
| 01:42 ET | 4214 | 83.41 |
| 01:44 ET | 4645 | 83.42 |
| 01:46 ET | 7197 | 83.41 |
| 01:48 ET | 2357 | 83.41 |
| 01:50 ET | 19510 | 83.3636 |
| 01:51 ET | 16997 | 83.34 |
| 01:53 ET | 4481 | 83.32 |
| 01:55 ET | 7609 | 83.35 |
| 01:57 ET | 10384 | 83.31 |
| 02:00 ET | 3726 | 83.36 |
| 02:02 ET | 8306 | 83.31 |
| 02:04 ET | 7884 | 83.32 |
| 02:06 ET | 6257 | 83.35 |
| 02:08 ET | 10608 | 83.4 |
| 02:09 ET | 5492 | 83.43 |
| 02:11 ET | 6978 | 83.445 |
| 02:13 ET | 5228 | 83.43 |
| 02:15 ET | 9654 | 83.43 |
| 02:18 ET | 18565 | 83.375 |
| 02:20 ET | 7484 | 83.39 |
| 02:22 ET | 8262 | 83.295 |
| 02:24 ET | 21467 | 83.23 |
| 02:26 ET | 12605 | 83.23 |
| 02:27 ET | 7707 | 83.15 |
| 02:29 ET | 5428 | 83.215 |
| 02:31 ET | 7280 | 83.22 |
| 02:33 ET | 6052 | 83.275 |
| 02:36 ET | 12956 | 83.345 |
| 02:38 ET | 14649 | 83.4 |
| 02:40 ET | 13811 | 83.42 |
| 02:42 ET | 7373 | 83.48 |
| 02:44 ET | 7238 | 83.512 |
| 02:45 ET | 16537 | 83.49 |
| 02:47 ET | 4928 | 83.53 |
| 02:49 ET | 11740 | 83.54 |
| 02:51 ET | 5790 | 83.53 |
| 02:54 ET | 10042 | 83.495 |
| 02:56 ET | 7537 | 83.57 |
| 02:58 ET | 8860 | 83.59 |
| 03:00 ET | 3143 | 83.55 |
| 03:02 ET | 9683 | 83.55 |
| 03:03 ET | 5063 | 83.56 |
| 03:05 ET | 9415 | 83.54 |
| 03:07 ET | 5289 | 83.57 |
| 03:09 ET | 8692 | 83.56 |
| 03:12 ET | 7978 | 83.545 |
| 03:14 ET | 8927 | 83.52 |
| 03:16 ET | 8652 | 83.551 |
| 03:18 ET | 9543 | 83.575 |
| 03:20 ET | 19871 | 83.66 |
| 03:21 ET | 6436 | 83.6699 |
| 03:23 ET | 2680 | 83.675 |
| 03:25 ET | 13971 | 83.64 |
| 03:27 ET | 7160 | 83.66 |
| 03:30 ET | 72630 | 83.5125 |
| 03:32 ET | 8820 | 83.527 |
| 03:34 ET | 22216 | 83.455 |
| 03:36 ET | 9465 | 83.485 |
| 03:38 ET | 17281 | 83.495 |
| 03:39 ET | 44401 | 83.495 |
| 03:41 ET | 40599 | 83.51 |
| 03:43 ET | 15022 | 83.58 |
| 03:45 ET | 9227 | 83.62 |
| 03:48 ET | 14179 | 83.68 |
| 03:50 ET | 35595 | 83.61 |
| 03:52 ET | 32480 | 83.62 |
| 03:54 ET | 30772 | 83.69 |
| 03:56 ET | 74294 | 83.77 |
| 03:57 ET | 85170 | 83.86 |
| 03:59 ET | 1568148 | 83.84 |
Sep 25, 2024
Championing HIV Services for LGBTQ+ Youth, from 9:56AM ET on Wednesday Sep 25, 2024 by Dow Jones
9:56AM ET on Wednesday Sep 25, 2024 by Dow Jones
Sep 23, 2024
DJ Novo CEO Faces Sanders Over GLP-1 Drug Prices. All of Pharma Should Tune In. -- Barrons.com, from 2:30AM ET on Monday Sep 23, 2024 by Dow Jones
2:30AM ET on Monday Sep 23, 2024 by Dow Jones
Sep 18, 2024
Working to Build Next-Generation Cancer Therapies, from 1:34PM ET on Wednesday Sep 18, 2024 by Dow Jones
1:34PM ET on Wednesday Sep 18, 2024 by Dow Jones
Sep 16, 2024
DJ Gilead Sciences Price Target Maintained With a $70.00/Share by Cantor Fitzgerald, from 11:56AM ET on Monday Sep 16, 2024 by Dow Jones
11:56AM ET on Monday Sep 16, 2024 by Dow Jones
Sep 12, 2024
DJ Gilead Stock Rises on Positive Study Results for Twice-Yearly HIV Drug -- WSJ, from 10:07AM ET on Thursday Sep 12, 2024 by Dow Jones
10:07AM ET on Thursday Sep 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Gilead Sciences Inc | 103.1B | 102.4x | +1.53% |
Haleon PLC | 47.1B | 33.6x | --- |
Amgen Inc | 178.6B | 55.5x | -0.22% |
Bristol-Myers Squibb Co | 101.3B | -15.9x | +4.90% |
Teva Pharmaceutical Industries Ltd | 20.6B | -43.3x | --- |
Viatris Inc | 13.9B | -21.4x | -41.37% |
Company Information
Gilead Sciences, Inc. is a biopharmaceutical company. It is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis, coronavirus disease 2019 (COVID-19) and cancer. It is focused on the discovery, development and commercialization of medicines in areas of unmet medical need. Its portfolio of marketed products includes AmBisome, Atripla, Biktarvy, Cayston, Complera, Descovy, Descovy for PrEP, Emtriva, Epclusa, Eviplera, Genvoya, Harvoni, Hepcludex, Hepsera, Jyseleca, Letairis, Odefsey, Sovaldi, Stribild, Sunlenca, Tecartus, Trodelvy, Truvada, Truvada for PrEP, Tybost, Veklury, Vemlidy, Viread, Vosevi, Yescarta and Zydelig. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, and Domvanalimab and zimberelimab, and seladelpar. Seladelpar shall be used for the treatment of primary biliary cholangitis (PBC), including pruritus. The Company operates in more than 35 countries.
Contact Information
- Headquarters
- 333 LAKESIDE DRFOSTER CITY, CA, United States 94404
- Phone
- 650-574-3000
- Fax
- 650-578-9264
Executives
- Chairman of the Board, Chief Executive Officer
- Daniel O'Day
- Chief Financial Officer
- Andrew Dickinson
- Executive Vice President - Corporate Affairs, General Counsel
- Deborah Telman
- Chief Commercial Officer
- Johanna Mercier
- Chief Medical Officer
- Merdad Parsey
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $103.1B |
|---|---|
Revenue (TTM) | $27.8B |
Shares Outstanding | 1.2B |
Dividend Yield | 3.67% |
Annual Dividend Rate | 3.0800 USD |
Ex-Dividend Date | 09-13-24 |
Pay Date | 09-27-24 |
Beta | 0.20 |
EPS | $0.82 |
Book Value | $18.33 |
P/E Ratio | 102.4x |
Price/Sales (TTM) | 3.7 |
Price/Cash Flow (TTM) | 27.2x |
Operating Margin | 9.20% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
